Publicações científicas

Clinical guideline for management of patients with low risk differentiated thyroid carcinoma

Díez JJ(1), Oleaga A(2), Álvarez-Escolá C(3), Martín T(4), Galofré JC [ES](5); en representación del Grupo de Trabajo de Cáncer de Tiroides de la Sociedad Española de Endocrinología y Nutrición.
(1) Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Universidad de Alcalá de Henares, Madrid, España.
(2) Servicio de Endocrinología y Nutrición, Hospital Universitario Basurto, Bilbao, España.
(3) Servicio de Endocrinología y Nutrición, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, España.
(4) Servicio de Endocrinología, Hospital Universitario Virgen Macarena, Sevilla, España.
(5) Departamento de Endocrinología, Clínica Universidad de Navarra, Pamplona, España. 

Revisão:Endocrinología y Nutrición

Data: 6/Abr/2015

Área de Patología da Tiroide Endocrinologia e Nutrição [ES]

RESUMO

Incidence of thyroid cancer is increasing in Spain and worldwide. Overall thyroid cancer survival is very high, and stratification systems to reliably identify patients with worse prognosis have been developed.

However, marked differences exist between the different specialists in clinical management of low-risk patients with thyroid carcinoma. Almost half of all papillary thyroid carcinomas are microcarcinomas, and 90% are tumors < 2cm that have a particularly good prognosis. However, they are usually treated more aggressively than needed, despite the lack of adequate scientific support.

Surgery remains the gold standard treatment for these tumors. However, lobectomy may be adequate in most patients, without the need for total thyroidectomy. Similarly, prophylactic lymph node dissection of the central compartment is not required in most cases.

This more conservative approach prevents postoperative complications such as hypoparathyroidism or recurrent laryngeal nerve injury. Postoperative radioiodine remnant ablation and strict suppression of serum thyrotropin, although effective for the more aggressive forms of thyroid cancer, have not been shown to be beneficial for the treatment of low risk patients, and may impair their quality of life.

This guideline provides recommendations from the task force on thyroid cancer of the Spanish Society of Endocrinology and Nutrition for adequate management of patients with low-risk thyroid cancer.

CITAÇÃO DO ARTIGO  Endocrinol Nutr. 2015 Apr 6. pii: S1575-0922(15)00076-5. doi: 10.1016/j.endonu.2015.02.006

talvezlhe interesse

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra